These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 24019180

  • 1. Immunotherapy for acne vulgaris: current status and future directions.
    Simonart T.
    Am J Clin Dermatol; 2013 Dec; 14(6):429-35. PubMed ID: 24019180
    [Abstract] [Full Text] [Related]

  • 2. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
    Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, Dreno B.
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
    [Abstract] [Full Text] [Related]

  • 3. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.
    Liu PF, Hsieh YD, Lin YC, Two A, Shu CW, Huang CM.
    Curr Drug Metab; 2015 Mar; 16(4):245-54. PubMed ID: 26264195
    [Abstract] [Full Text] [Related]

  • 4. Acne vaccines targeting Propionibacterium acnes.
    Kao M, Huang CM.
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [Abstract] [Full Text] [Related]

  • 5. Vaccinating against Acne: Benefits and Potential Pitfalls.
    Contassot E.
    J Invest Dermatol; 2018 Nov; 138(11):2304-2306. PubMed ID: 30170784
    [Abstract] [Full Text] [Related]

  • 6. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes.
    Keshari S, Kumar M, Balasubramaniam A, Chang TW, Tong Y, Huang CM.
    Expert Rev Vaccines; 2019 May; 18(5):433-437. PubMed ID: 30920859
    [Abstract] [Full Text] [Related]

  • 7. Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne.
    Miura Y, Ishige I, Soejima N, Suzuki Y, Uchida K, Kawana S, Eishi Y.
    J Med Dent Sci; 2010 Mar; 57(1):65-74. PubMed ID: 20437767
    [Abstract] [Full Text] [Related]

  • 8. What is new in the pathophysiology of acne, an overview.
    Dréno B.
    J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():8-12. PubMed ID: 28805938
    [Abstract] [Full Text] [Related]

  • 9. Propionibacterium acnes colonization in acne and nonacne.
    Leyden JJ, McGinley KJ, Vowels B.
    Dermatology; 1998 Sep; 196(1):55-8. PubMed ID: 9557227
    [Abstract] [Full Text] [Related]

  • 10. What is the role of antimicrobial peptides (AMP) in acne vulgaris?
    Harder J, Tsuruta D, Murakami M, Kurokawa I.
    Exp Dermatol; 2013 Jun; 22(6):386-91. PubMed ID: 23711061
    [Abstract] [Full Text] [Related]

  • 11. On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients.
    Gloor M, Franke M.
    Arch Dermatol Res; 1978 Jun 29; 262(1):125-9. PubMed ID: 150822
    [Abstract] [Full Text] [Related]

  • 12. Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris.
    Liu PF, Nakatsuji T, Zhu W, Gallo RL, Huang CM.
    Vaccine; 2011 Apr 12; 29(17):3230-8. PubMed ID: 21354482
    [Abstract] [Full Text] [Related]

  • 13. The evolving role of Propionibacterium acnes in acne.
    Leyden JJ.
    Semin Cutan Med Surg; 2001 Sep 12; 20(3):139-43. PubMed ID: 11594668
    [Abstract] [Full Text] [Related]

  • 14. Biofilms in skin infections: Propionibacterium acnes and acne vulgaris.
    Coenye T, Honraet K, Rossel B, Nelis HJ.
    Infect Disord Drug Targets; 2008 Sep 12; 8(3):156-9. PubMed ID: 18782032
    [Abstract] [Full Text] [Related]

  • 15. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
    Wang Y, Hata TR, Tong YL, Kao MS, Zouboulis CC, Gallo RL, Huang CM.
    J Invest Dermatol; 2018 Nov 12; 138(11):2355-2364. PubMed ID: 29964032
    [Abstract] [Full Text] [Related]

  • 16. Is acne vulgaris a genuine inflammatory disease?
    Zouboulis CC.
    Dermatology; 2001 Nov 12; 203(4):277-9. PubMed ID: 11752811
    [No Abstract] [Full Text] [Related]

  • 17. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes.
    Li ZJ, Choi DK, Sohn KC, Seo MS, Lee HE, Lee Y, Seo YJ, Lee YH, Shi G, Zouboulis CC, Kim CD, Lee JH, Im M.
    J Invest Dermatol; 2014 Nov 12; 134(11):2747-2756. PubMed ID: 24820890
    [Abstract] [Full Text] [Related]

  • 18. [On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients. Investigations on juvenile acne patients with predominant comedones and healthy controls (author's transl)].
    Gloor M, Lamerz A, Höffler U, Franke M.
    Dermatol Monatsschr; 1980 Dec 12; 166(12):798-803. PubMed ID: 6452296
    [No Abstract] [Full Text] [Related]

  • 19. Acne: a new model of immune-mediated chronic inflammatory skin disease.
    Antiga E, Verdelli A, Bonciani D, Bonciolini V, Caproni M, Fabbri P.
    G Ital Dermatol Venereol; 2015 Apr 12; 150(2):247-54. PubMed ID: 25876146
    [Abstract] [Full Text] [Related]

  • 20. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
    Whiteside JA, Voss JG.
    J Invest Dermatol; 1973 Feb 12; 60(2):94-7. PubMed ID: 4266325
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.